The New Era of Christian Ethical Investing.

~ 30% of your index fund finances what you reject.

GoodWay evaluates your portfolio through Christian Social Doctrine, an ethical framework that not only explains each misalignment, but finds you one or several ethical alternatives for every portfolio position, one that matches your current returns.

01 — Rating

Triage

Every position assessed in terms of CST compliance

02 — Diagnosis

Exploration

We explain in detail each misalignment and why it matters

03 — Alternatives

Prescription

Ethical alternatives that match or beat your returns — because ethics should never mean giving up profitability

Explore the GoodWay Rating

See the GoodWay Diagnostic in action.

Request a sample portfolio report — rating, diagnosis, and ethical alternatives.

Global Equity Fund

LU0203975437

Abbott Labs Health

—

Citigroup Finance

—

Danaher Corp Health

—

Novo Nordisk Pharma

—

Unilever Consumer

—

GoodWay Score 0/100

The Problem

Most Christian investors are unknowingly funding what they reject.

The Context

− Close

Index funds now dominate global investing.

As of December 2025, indexed funds represent 62.8% of all US domestic equity fund assets. Passive management now accounts for between 33.5% and 35% of the entire US stock market. This shift is structural and accelerating worldwide.

62.8% of US equity assets are indexed

ICI, December 2025

The Reach

− Close

Christian investors are fully part of this trend.

62% of US adults invest in the stock market. 56.4% of US households own registered investment funds. Given that index funds are the default option in most retirement plans, the vast majority have direct exposure to passive vehicles.

62% of US adults invest · 56.4% own funds

Gallup, May 2025 · ICI, 2025

The Consequence

− Close

~30% of those indices diverge from Christian Social Teaching.

A significant share of the market capitalisation of major indices (including the MSCI World, S&P 500, and STOXX Europe 600) does not meet CST criteria. The gap is not about intent, but about the lack of the right tools.

~30% non-compliant across major indices

GoodWay Research · Mensuram Bonam, 2022

The Solution

We show you what's wrong. Then we fix it.

Rating

Every position is assessed in terms of CST compliance

Diagnosis

The exact misalignment, the criterion, and the exposure.

Alternatives

A CST-compliant match with same sector and validated returns.

Original Portfolio

0 /100

GoodWay Score

50 holdings · 33 ethical · 17 non-compliant

Exposure to non-compliant themes

Nuclear Weapons 11.75%

Adult Entertainment 6.43%

Embryonic Stem Cell 5.99%

Performance (5yr)

+31%

Return

14.2%

Volatility

1.98

Sharpe

GoodWay
Diagnostic

→

Ethical Portfolio

0 /100

GoodWay Score

50 holdings · 47 ethical · 14 replacements

Exposure after transformation

Nuclear Weapons 2.44% (-79%)

Adult Entertainment 3.25% (-49%)

Embryonic Stem Cell 0% (-100%)

Performance (5yr)

+36%

Return

15.2%

Volatility

2.11

Sharpe

See How It Works

The Foundation

2,000 years of philosophy.
35 years of quant finance.

GoodWay is ETS Asset Management Factory's proprietary rating system, applying Christian Social Teaching criteria, grounded in Aristotle and codified in Mensuram Bonam, to the quantitative analysis of capital markets. Validated by an independent Ethics Committee. €3.4B under management.

0K+

Companies rated

Fund classes

0K+

ETF listings

Processing

Your portfolio, diagnosed.

Submit your positions. Receive a detailed CST compliance report.

Request Diagnosis

Holdings

Nestlé

—

Abbott Laboratories

—

SAP

—

Thermo Fisher Scientific

—

T-Mobile US

—

Microsoft

—

Citigroup

—

ASML

—

Merck KGaA

—

Novo Nordisk

—

Showing 10 of 50 holdings

Awaiting analysis

GoodWay Portfolio Score

33/50

Ethical holdings

Non-compliant

Non-compliant holdings (35.45% exposure)

✕ Abbott Laboratories

Contraceptives

✕ Citigroup

Nuclear Weapons

✕ T-Mobile US

Adult Entertainment

✕ Merck KGaA

Abortifacients

✕ Danaher

Embryonic Stem Cell

+ 12 more non-compliant holdings

Our Solutions

Choose the path that fits you.

Offer GoodWay to your clients

Integrate the GoodWay Rating into your advisory practice.

White-label reports, platform integration, and a scalable framework for every client relationship.

Private BanksWealth ManagersIFAs / EAFsFamily Office Advisors

For wealth advisors

Align your own portfolio

Diagnose your positions and discover ethical alternatives.

Full CST assessment, detailed diagnosis, and verified alternatives that match or beat your returns.

Individual InvestorsFamily OfficesFoundationsReligious Congregations

For investors

The GoodWay Decalogue

Ethics are not rules.
They are practices.

GoodWay is built on ten principles tracing the philosophical foundations of virtuous finance, from Aristotle's practical philosophy to Christian Social Teaching.

These foundations are accessible to every human being, regardless of faith. The reasons why certain financial practices fall short of the human good are not matters of dogma. They are matters of reason.

"Virtuous finances are not those that comply with certain rules, but those that are appropriate to the good due in each circumstance."

— GoodWay Decalogue, Principle 9

Read the Decalogue

The Heritage

A millennia-old framework.

2,000 years of ethical philosophy. 130 years of systematic economic doctrine. 35 years of quantitative finance.

4th C. BC

Aristotle

Ethics as practical philosophy. The common good as economic criterion.

1st C. AD

The Gospel

Dignity of human life as absolute moral criterion.

1891

Rerum Novarum

First systematic modern economic ethics.

2022

Mensuram Bonam

Vatican update of CST criteria for contemporary investment.

2025

GoodWay™

2,000 years of ethics + 35 years of quant finance.

Sample Reports

More than a rating.
See the system in action.

Our reports go beyond a score. Each one shows a full CST assessment breakdown and, where applicable, ETS Similarity Score alternatives with verified return data.

The reports below are illustrative samples. Full library access requires a professional or investor account.

Get Full Access For Investors

Lyxor MSCI World Catholic

IE000AZOUN82

85 /100

High-scoring alternative. Frequent ETS candidate for S&P 500 positions.

View →

BSF BlackRock ESG World

LU1254583351

65 /100

ESG-rated but CST non-compliant. Key ESG vs GoodWay case study.

View →

Mutuafondo Salud FI

ES0131369011

100 /100

Perfect GoodWay score. CST-aligned healthcare benchmark.

View →

AB Intl Technology

LU0260065114

87 /100

Highest-rated technology fund in the GoodWay universe.

View →

The New Era of Christian Ethical Investing.

See the GoodWay Diagnostic in action.

Most Christian investors are unknowingly funding what they reject.

Index funds now dominate global investing.

Christian investors are fully part of this trend.

~30% of those indices diverge from Christian Social Teaching.

We show you what's wrong. Then we fix it.

2,000 years of philosophy. 35 years of quant finance.

Your portfolio, diagnosed.

Choose the path that fits you.

Integrate the GoodWay Rating into your advisory practice.

Diagnose your positions and discover ethical alternatives.

Ethics are not rules.They are practices.

A millennia-old framework.

More than a rating.See the system in action.

2,000 years of philosophy.
35 years of quant finance.

Ethics are not rules.
They are practices.

More than a rating.
See the system in action.